SCHEMBL2407247

SCHEMBL2407247

C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccc(C(=O)O)c(C(C)(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EEF2K O00418 3/20 0.55
MMP7 P09237 2/20 0.50
MMP9 P14780 2/20 0.50
MMP13 P45452 2/20 0.50
MMP1 P03956 1/20 0.50
MMP2 P08253 1/20 0.50
MMP3 P08254 1/20 0.50
ACLY P53396 1/20 0.47
KDM1A O60341 3/20 0.46
SLC1A3 P43003 1/20 0.46
SLC1A2 P43004 1/20 0.46
SLC1A1 P43005 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
CYP3A4 P08684 4/20 0.42
CYP2C19 P33261 4/20 0.42
CYP2C9 P11712 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
MAPK1 P28482 2/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2413992 0.80 MMP7 (0.47) EEF2KMMP7MMP9MMP13MMP1
SCHEMBL2412670 0.75 MMP7 (0.52) EEF2KMMP7MMP9MMP13MMP1
SCHEMBL2413093 0.75 MMP7 (0.52) EEF2KMMP7MMP9MMP13MMP1
SCHEMBL2407249 0.74 CYP3A4 (0.53) EEF2KMMP7MMP9MMP13MMP1
SCHEMBL2412284 0.74 CYP3A4 (0.53) EEF2KMMP7MMP9MMP13MMP1
SCHEMBL2406492 0.73 EEF2K (0.49) EEF2KMMP7MMP9MMP13MMP1
SCHEMBL3764440 0.71 NPSR1 (0.46) MMP7MMP9MMP13MMP1MMP2
SCHEMBL26603343 0.70 GAA (0.53) MMP7MMP9MMP13MMP1MMP2
SCHEMBL10699529 0.70 CYP2C9 (0.46) CYP2C19CYP2C9CYP2D6LMNAPOLB
SCHEMBL12377249 0.70 CA1 (0.61) EEF2KMMP7MMP9MMP13MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC10, HDAC1 EEF2K 1208/4885MMP7 914/4885MMP9 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.